Sex difference in response of blood pressure to calcium antagonism in the treatment of moderate-to-severe hypertension

Blood Pressure Monitoring

Volumn 4, Issue 5, 1999, Pages 209-212

  Loeb, Ethan D ^a   Diamond, Joseph A ^a   Krakoff, Lawrence R ^a   Phillips, Robert A ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ambulatory blood pressure monitoring; Calcium antagonist; Sex; White coat effect

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; NIFEDIPINE; VERAPAMIL;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MALE; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 0033511762     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-199900450-00001     Document Type: Article

References (13)

1. 1 Pickering TG, Harshfield GA, Devereux RB, Laragh JH. What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension 1985; 7:171-177.
2. 2 Hoegholm A, Kristensen KS, Madsen NH, Svendsen TL. White coat hypertension diagnosed by 24-h ambulatory monitoring. Examination of 159 newly diagnosed hypertensive patients. Am J Hypertens 1992; 5:64-70.
3. 3 Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259:225-228.
4. 4 Eison H, Phillips RA, Ardeljan M, Krakoff LR. Differences in ambulatory blood pressure between men and women with mild hypertension. J Hum Hypertens 1990; 4:400-404.
5. 5 Krakoff LR, Bravo EL, Tuck ML, Friedman CP. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. Am J Hypertens 1990; 3:318S-325S.
6. 6 Kloner RA, Sowers JR, DiBona GF, Gaffney M, Wein M. Sex- and age-related antihypertensive effects of amlodipine. Am J Cardiol 1996; 77:713-722.
7. 7 Moore CR, Krakoff LR, Phillips RA. Confirmation or exclusion of stage I hypertension by ambulatory blood pressure monitoring. Hypertension 1997; 29:1109-1113.
8. 8 Pickering TG, Levenstein M, Walmsley P. Differential effects of doxazosin on clinic and ambulatory pressure according to age, gender, and presence of white coat hypertension. Results of the HALT Study. Am J Hypertens 1994; 7:848-852.
9. 9 Herpin D, Vaisse B, Pitiot M. Comparison of angiotensin-converting enzyme inhibitors and calcium antagonists in the treatment of mild to moderate systemic hypertension, according to baseline ambulatory blood pressure level. Am J Cardiol 1992; 69:923-926.
10. 10 Ashida T, Abe H, Kawano Y, Yoshida K, Kimura G, Kojima S, et al. Effects of nifedipine SR and enalapril on office, home and ambulatory blood pressure in 'white-coat' systemic hypertension. Am J Cardiol 1990, 66:498-501.
11. 11 Gould BA, Mann S, Davies AB, Altman DG, Raftery EB. Does placebo lower blood-pressure? Lancet 1981; ii:1377-1381.
12. 12 Dupont AG, Van der Niepen P, Six RO. Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol 1987; 24:106-109.
13. 13 Mutti E, Trazzi S, Omboni S, Parati G, Mancia G. Effect of placebo on 24-h non-invasive ambulatory blood pressure. J Hypertens 1991; 9:361-364.